The Global Market for Continuous Glucose Monitoring Devices and Diabetes-Related Market Should Reach Nearly $12.8 Billion in 2017 and $20.7 Billion in 2022, Registering a CAGR of 10.1%
Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
The scope of this study encompasses the current and forecast markets for glucose monitoring, as well as pumps, SMBG meters and test strips. The covered segments are CGM transmitters, receivers and sensors, patch and durable insulin pumps, and self-monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all usage of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM device.
Calibration may be required once or twice a day, or even less often, as the devices improve in the near future. Inclusion of SMBG meters and test strips will help the reader to comprehend the relative sizes of the two major segments: CGM and SMBG. As discussed elsewhere in this report, developing countries will continue to use primarily SMBG, as these devices are not only much cheaper than CGM, but, for many diabetics, do just fine for monitoring blood glucose.
The report also includes discussions of the reimbursement and regulatory environments, current and developing technologies, diabetes incidence, market projections and market shares, and the latest trends and clinical trials.
Key Topics Covered:
1: Introduction
2: Summary and Highlights
3: Market and Technology Background
History and Current State of Blood Glucose Monitoring Technology
Working to Improve CGM Technology
Healthcare Insurance and Reimbursement for CGM Systems and Pumps
In-depth focus on diabetes
Global Obesity and the Rise of Diabetes
4: Market Breakdown by Technology Type
Total Global Market, 2016 Through 2022
Global CGM Markets
Global Insulin Pump Markets
Global SMBG Meters and Test Strips Markets
5: Market Breakdown by Testing Location
6: CGM and SMBG Markets by Type of Diabetes
CGM Markets by Type of Diabetes
SMBG and Test Strip Markets, by Type of Diabetes
7: CGM Markets by User's Age
8: Market Breakdown by Region
Regional Markets for CGMs, Patch Pumps, Durable Pumps, SMBG Meters and Test Strips
CGM Markets by Region
Insulin Pump Markets by Region
SMBG Meters and Test Strip Markets by Region
9: Patent Review/ New Developments
Patent Review
New Developments
10: Analysis of Market Opportunities
11: Company Profiles
Abbott Labs
Apple Inc.
Arkray Inc.
Ascensia Diabetes Care Holdings Ag
Beta Bionics Inc.
Bigfoot Biomedical
Cellnovo Group
Cequr Sa
Cnoga Medical Ltd.
Debiotech S.A.
Glooko Inc.
Glucovation
Glysens
Insulet Corp.
Intarcia Therapeutics
Integrity Applications
Intuity Medical Inc.
Johnson & Johnson
Animas Corp. (Jnj)
Calibra Medical (Jnj)
Lifescan (Jnj)
Labstyle Innovations Corp. (Dariohealth Corp.)
Medtronic
Novo Nordisk
Onduo
One Drop
Roche
Sanofi
Senseonics Holdings Inc.
Sinocare Inc.
Tandem Diabetes Care
Unilife Corp.
Valeritas Inc.
Viacyte
Ypsomed AG
12: Appendix: CGM and Diabetes-related Device Markets
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...
Product: Meat and vegetable products
Issue: Food - Microbial Contamination - Listeria
Distribution:British Columbia
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...